companydata.dkLIPLASOME PHARMA ApS: Financial statements 2016
CVR: 29428514
LIPLASOME PHARMA ApS (CVR 29428514) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -328,000 and a net result of DKK -309,000 compared with DKK -2,491,000 the year before. Equity amounted to DKK 33,893,000. The solvency ratio was 88.7%.
- Gross Profit
- -328,000 kr.
- Profit/Loss
- -309,000 kr.
- Equity
- 33,893,000 kr.
- Total Assets
- 38,190,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -328 t. | -309 t. | 33.9 mio. | 0 |
| 2015 | - | -1.7 mio. | -2.5 mio. | 34.2 mio. | 2 |
| 2014 | - | -1.5 mio. | -2.4 mio. | 31.8 mio. | 2 |
| 2013 | - | -1.2 mio. | -147 t. | 34.2 mio. | 2 |
| 2012 | - | -850 t. | -3 mio. | 19.7 mio. | 2 |
How creditworthy is LIPLASOME PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
LIPLASOME PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -1,723,000, and the net result was DKK -2,491,000.
As of February 15, 2016, Sanjay Kumar Sehgal has joined the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Peter Buhl has left the board of directors of LIPLASOME PHARMA ApS.
As of February 15, 2016, Duncan Moore has left the board of directors of LIPLASOME PHARMA ApS.
About LIPLASOME PHARMA ApS
LIPLASOME PHARMA ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Horsted Eriksen. The company is owned by BAGGER-SØRENSEN & CO. A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -28,000 and a net result of DKK 62,000 compared with DKK -36,000 the year before. Equity amounted to DKK 2,377,000.